Dr. Desai treats a young, active male affected by May-Thurner Syndrome with a single interventional treatment session.
Dr. Scott Koss discusses treating an acute thrombosis from a patient’s common iliac vein to her calf vein using ZelanteDVT™.
Resources
All Case Study Resources (-)
-
Treating Acute DVT in Patient with May-Thurner Syndrome
Jan 26, 2018
External Link( 15.0 KB )
See the AngioJet™ ZelanteDVT™ Thrombectomy System in a staged intervention of an acute DVT in a patient with May-Thurner Syndrome.
-
Acute DVT Lower Left Extremity Revascularization Case Study
PDF( 1.0 MB )
Dr. David Wilson’s case study reviews an acute DVT treated with the AngioJet™ ZelanteDVT™ pharmacomechanical thrombectomy.
-
Ambulatory Venous Thrombectomy Case Study
PDF( 758.0 KB )
Dr. Jeffrey Y. Wang shows how early thrombectomy of large iliofemoral DVT using the AngioJet™ ZelanteDVT™ can be used to help remove venous thrombus and help reduce the risk of short- and long-term complications.
-
Extensive DVT of the Femoral and External Iliac Veins Case Study
PDF( 2.0 MB )
Dr. Jeffrey Y. Wang’s case study reviews an AngioJet™ ZelanteDVT™ thrombectomy performed on an extensive DVT from the popliteal extending into the external iliac vein.
-
Extensive Iliofemoral Thrombus Revascularization Case Study
PDF( 181.0 KB )
Dr. Charles Wyble reviews a pharmacomechanical thrombectomy case study using the AngioJet™ ZelanteDVT™ Thrombectomy Catheter.
-
Management of Acute DVT Case Study
PDF( 510.0 KB )
Dr. Christopher Grilli uses dual vein access to treat extensive thrombus from the popliteal into the iliac vein.
-
Significant Removal of Large-Vessel Thrombus Case Study
PDF( 1.0 MB )
Dr. Eric Schoch and Dr. Christoph Binkert review the case of a 76-year-old woman with hyperechoic acute thrombus in the left common femoral vein, which was treated using the 8-F AngioJet™ ZelanteDVT™ Catheter.
PEARL Registry
Read the summary of a two-phase, non-randomized study of the AngioJetTM Thrombectomy Catheters, which followed 372 DVT patients in 34 enrolling sites and four countries to determine the efficacy of thrombus removal.